Disseminated Intravascular Coagulation in the Obstetric Patient
Disseminated intravascular coagulation (DIC) has been suggested to be a syndrome rather than a disease. This syndrome is often connected to a systemic pathology and is always secondary to an underlying disease. DIC is characterised by a systemic activation of coagulation system, with the generation and deposition of fibrin and microvascular thrombi in various organs. It is a systemic thrombohaemorrhagic disorder associated with a well-defined clinical situation, laboratory evidence of procoagulant activation, fibrinolytic activation, inhibitor consumption and biochemical evidence of end-organ dysfunction [1, 2, 3].
KeywordsDisseminate Intravascular Coagulation Disseminate Intravascular Coagulation Recurrent Pregnancy Loss HELLP Syndrome Procoagulant Activation
Unable to display preview. Download preview PDF.
- 2.Bick LR, Murano G (1994) Physiology of hemostasis Clin Lab Med 14: 677–708.Google Scholar
- 3.Brozovic M (1987) Disseminated intravascular coagulation. In: Haemostasis and Thrombosis Churchill-Livingstone, pp: 535–541Google Scholar
- 9.Gore M, Eldon S, Trofatter KF et al (1987) Pregnancy induced changes in the fibrinolytic balance evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor. Am J Obst Gynecol 156: 674–680.Google Scholar
- 11.Reister F, Heil W, Rath W (1997) Coagulation disorders in Obstetrics. Biom Progr 10: 62–67.Google Scholar
- 13.Mangione S, Giarratano A, Leone I, Mangione D (1996) Monitoraggio e trattamento delle coagulopatie in ostetricia ad alto rischio. Min Anes 62: 623–626.Google Scholar
- 17.Stormorken H (1979) Interrelationship between coagulation, the fibrinolytic and the kallikrein and kinin system.Scandin J Hematol 34: 24–27Google Scholar
- 18.Maki M, Takao K, Terao T, et al (2000) Atithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. Thromb Hemost; 84: 583–90Google Scholar
- 20.Giarratano A, Capogna G, Celleno D, et al (2000) A new approach in the treatment of severe preeclampsia and HELLP syndrome using high doses of Antithrombin III. 26s3:S321–417Google Scholar